Healthcare Facilities company Global Health announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Consolidated Total Income of Rs 9,542 million, grew by 14.1% YoY, primarily led by patient volume growth EBITDA was Rs 2,476 million, growth of 19.8% YoY. EBITDA margins improved from 24.7% in Q4FY24 to 26.0% in Q4FY25 Profit After Tax was Rs 1,014 million with PAT margins of 10.6% In Q4FY25 Profit After Tax is impacted due to non-recurring exceptional expense item of Rs 499 million arising due to merger of MHPL with GHL. Adjusted PAT was Rs 1,387 million with margins of 14.5% and growth of 8.9% YoY FY25 Financial Highlights: Consolidated Total Income of Rs 37,714 million, grew by 12.6% YoY. The growth was primarily driven by increase in patient volumes EBITDA was Rs 9,562 million, growth of 9.4% YoY. EBITDA margins stood at 25.4% compared to 26.1% in FY24 Profit After Tax was Rs 4,813 million, with PAT margins of 12.8% Profit After Tax was impacted due to non-recurring exceptional expense item of Rs 499 million arising due to merger of MHPL (Lucknow entity) with GHL. Adjusted PAT was Rs 5,186 million with margins of 13.8% and growth of 8.5% YoY The board of directors have recommended a final dividend of 25% on the face value of Rs 2 per share i.e. Rs 0.50 per share Commenting on FY2025 results, Pankaj Sahni, Group CEO and Director said: "FY2025 was a landmark year for us as we celebrated 15 years of our flagship facility in Gurugram – the foundation of our journey in delivering world-class, patient-centric care. We are deeply honoured that Medanta Gurugram, also known as “The Medicity,” has been ranked India’s Best Private Hospital by Newsweek for the sixth consecutive year. This recognition is a testament to our unwavering focus on clinical excellence and innovation. Throughout the year, we remained steadfast in our commitment to providing the highest quality of patient care while continuing to invest in strengthening our clinical and technological capabilities across the Group. We are excited about our upcoming 550-bed facility in Noida, which is on track to commence operations in Q2 FY2026. This is part of a broader plan to add 1,000 beds over the next two years, enhancing our capacity to serve growing patient needs. In addition, we announced three significant greenfield projects in the high-growth markets of Mumbai, Pitampura, and Guwahati. These projects, expected to be operational in the next 3–4 years, will not only expand our footprint but also meaningfully diversify our presence across the country" Result PDF